Remedy Plan Therapeutics Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
Remedy Plan Therapeutics is a small biotechnology company based in Gaithersburg, Maryland, focused on developing therapies that modulate NAMPT activity. It pursues a tunable, hyperbolic NAMPT inhibition approach intended to minimize on-target toxicity while addressing dysregulation associated with multiple conditions. The company is building a pipeline of NAMPT inhibitors aimed at solid tumors, hematologic malignancies, obesity, and autoimmune disorders. Its lead candidate, RPT1G, has progressed into clinical development, with results from a first-in-human Phase 1 healthy volunteer study announced in December 2025. Remedy Plan operates within the biotechnology research industry from its Gaithersburg headquarters.